// App-Quantinova.ai

TCT-39 : Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index: TWILIGHT-BMI Analysis

Researchers

Presenter

  • Carlo Andrea Pivato

Principal Investigators

  • Davide Cao

  • Vijay Kunadian

  • Samantha Sartori

  • Zhongjie Zhang

  • George Dangas

  • Dominick Angiolillo

  • Carlo Briguori

  • David Cohen

  • C. Michael Gibson

  • David Moliterno

  • Samin Sharma

  • Javier Escaned

  • Stuart Pocock

  • Roxana Mehran

Medical Centers

  • Icahn School of Medicine at Mount Sinai, New York, New York, USA

  • Department of Biomedical Sciences, Humanitas University, Milan, Italy

  • University of Florida, Jacksonville, Florida, USA

  • Clinica Mediterranea, Naples, Italy.

  • University of Kentucky Lexington Kentucky USA

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Mount Sinai Medical Center, New York, New York, USA

  • Mount Sinai Medical Center, Scarsdale, New York, USA

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

  • St. Francis Hospital, New York, New York, USA

  • HOSPITAL CLINICO SAN CARLOS, MADRID, Spain

Locations

  • United States

  • United Kingdom

  • Italy

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Obesity

Biomarkers

  • N/A

Drug/Treatment

  • Ticagrelor

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved